5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Anthem Biosciences Ltd.

•
anthembio.comBSE: 544449NSE: ANTHEM
Market Cap₹ 53,098 Cr.
Current Price
High / Low₹ 978 / 579
Stock P/E85.1
Book Value₹ 58
Price to Book11.70
Dividend Yield0.21 %
ROCE31.3 %
ROE24.0 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Contract Manufacturing Development & Discovery Services (CRDMO): 82.8% • Speciality Ingredients: 17.2%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 29.0%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 22.5%
  • Company comfortably covers its interest (135.6x coverage)
  • Institutional investors have been accumulating - FII+DII up 11.0pp
  • Company generates healthy free cash flow

CONS

  • Promoter holding has decreased over last 2 years: -12.6pp
  • Stock is trading at 11.7x its book value
  • Operating margins have contracted to 39.6% from 48.1%
  • Expensive relative to growth - PEG of 4.2
  • Rich enterprise valuation - EV/EBITDA of 35.5x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTYLARGEMIDCAP250NIFTYMIDCAP150NIFTY MIDCAP 150NIFTY TOTAL MKTNIFTY 500
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.ANTHEM942.2592.1953098.430.21119.94-11.67418.22-22.5829.6236.00
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
339525498479538552417582384
215324331281343327254316276
Operating Profit123201167198195226163267108
OPM %36.40%38.26%33.49%41.36%36.32%40.86%39.14%45.84%28.07%
192824382854156229
Interest332222121
Depreciation181920212324272622
Profit before Tax122207170213199253150301136
Tax %29.88%17.72%24.67%42.42%25.43%21.66%25.30%29.62%25.19%
Net Profit85170128123148198112212102
1.533.042.292.192.653.542.003.771.81

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
3574626266331,1031,2311,0571,4181,8412,0891,935
2483414544516956646349131,1511,2381,172
Operating Profit109121172182408568423505689851763
OPM %30.51%26.18%27.43%28.75%36.97%46.10%40.03%35.63%37.44%40.74%39.45%
6102121374914771109158159
Interest5181820171299976
Depreciation22536162625864817810099
Profit before Tax8860114121366547498485711903840
Tax %24.94%40.73%32.22%23.18%25.79%25.72%22.52%22.69%28.85%25.75%25.73%
Net Profit66367793271406386375506671624
EPS78.5342.7491.23108.00323.41462.986.776.099.0511.94—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%16.75%—

COMPOUNDED SALES GROWTH

10 Years:
26%
5 Years:
14%
3 Years:
26%

COMPOUNDED PROFIT GROWTH

10 Years:
32%
5 Years:
20%
3 Years:
20%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
15%

RETURN ON EQUITY

10 Years:
29%
5 Years:
26%
3 Years:
23%
Last Year:
24%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jun 25

₹ 1

Rs.2.0000 per share(100%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
888889114112112112
2092443234136931,3471,6281,8212,3273,039
1762091601361206212218310745
Trade Payables3357545877657210011070
7787166159192244147186320440
Total Liabilities5046067117761,0911,7262,0832,4032,9763,707
252324316306361329449478624613
Capital Work in Progress4361250191531431565884
27773992092734994725331,380
5883921253558129211339119
0000000490448573
Cash & Bank115142241349343184166270
113183206174426564519412808669
Total Assets5046067117761,0911,7262,0832,4032,9763,707

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
00196211349456434164300889
Cash from Investing00-121-109-196-206-378-192-249-742
Cash from Financing00-65-48-6318153-132-68-44
009918308-6-159-17104

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2020Mar 2021Mar 2022Mar 2023Jul 2025Sep 2025Dec 2025Mar 2026Jun 2026
84.0082.9676.8576.8474.6974.6974.6974.6871.42
0.000.000.000.001.501.661.371.282.57
0.000.000.000.003.597.217.6011.5513.48
Government0.000.000.000.000.000.000.000.000.00
16.0017.0423.1523.1620.2216.4216.3512.4912.53

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08
Updates

2026-09-08 - Anthem Biosciences Limited has informed the Exchange regarding 'Settlement of Upside Sharing Arrangement '.

2026-07-27
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-27 - Anthem Biosciences Limited has informed the Exchange about Transcript

2026-07-24
Shareholders meeting

2026-07-24 - Anthem Biosciences Limited has submitted the Exchange the voting results and a copy Srutinizers report of the 20th Annual General Meeting held on July 22, 2026.

2026-07-22
Shareholders meeting

2026-07-22 - Anthem Biosciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 22, 2026

2026-07-22
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-22 - Anthem Biosciences Limited has informed the Exchange about Link of Recording

2026-07-22
Copy of Newspaper Publication

2026-07-22 - Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-21
Press Release (Revised)

2026-07-21 - Anthem Biosciences Limited has informed the Exchange regarding a revised press release dated July 21, 2026, titled "Press Release on Unaudited Financial Results for the Quarter ended June 30, 2026".

2026-07-21
Investor Presentation

2026-07-21 - Anthem Biosciences Limited has informed the Exchange about Investor Presentation

2026-07-21
Press Release

2026-07-21 - Anthem Biosciences Limited has informed the Exchange regarding a press release dated July 21, 2026, titled "Press Release on the Unaudited Financial Results for the quarter ended June 30, 2026".

News

Recent coverage and analyst commentary for ANTHEM

Loading news…

🤖

AI Stock Analyst

Anthem Biosciences Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login